134 related articles for article (PubMed ID: 12021868)
1. Novel peptides that inhibit the propagation of Newcastle disease virus.
Ramanujam P; Tan WS; Nathan S; Yusoff K
Arch Virol; 2002 May; 147(5):981-93. PubMed ID: 12021868
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of peptides that interact with Newcastle disease virus.
Chia SL; Tan WS; Shaari K; Abdul Rahman N; Yusoff K; Satyanarayanajois SD
Peptides; 2006 Jun; 27(6):1217-25. PubMed ID: 16377031
[TBL] [Abstract][Full Text] [Related]
3. A phage-displayed cyclic peptide that interacts tightly with the immunodominant region of hepatitis B surface antigen.
Tan WS; Tan GH; Yusoff K; Seow HF
J Clin Virol; 2005 Sep; 34(1):35-41. PubMed ID: 16087122
[TBL] [Abstract][Full Text] [Related]
4. Detection of virulent Newcastle disease virus using a phage-capturing dot blot assay.
Lee TC; Yusoff K; Nathan S; Tan WS
J Virol Methods; 2006 Sep; 136(1-2):224-9. PubMed ID: 16797732
[TBL] [Abstract][Full Text] [Related]
5. Identification of epitopes in the nucleocapsid protein of Nipah virus using a linear phage-displayed random peptide library.
Eshaghi M; Tan WS; Yusoff K
J Med Virol; 2005 Jan; 75(1):147-52. PubMed ID: 15543570
[TBL] [Abstract][Full Text] [Related]
6. Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.
Desjobert C; de Soultrait VR; Faure A; Parissi V; Litvak S; Tarrago-Litvak L; Fournier M
Biochemistry; 2004 Oct; 43(41):13097-105. PubMed ID: 15476403
[TBL] [Abstract][Full Text] [Related]
7. Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library.
Ho KL; Yusoff K; Seow HF; Tan WS
J Med Virol; 2003 Jan; 69(1):27-32. PubMed ID: 12436474
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.
Zang L; Shi L; Guo J; Pan Q; Wu W; Pan X; Wang J
Cancer Lett; 2009 Aug; 281(1):64-70. PubMed ID: 19327883
[TBL] [Abstract][Full Text] [Related]
9. Peptide ligands that bind IgM antibodies and block interaction with antigen.
Glee PM; Pincus SH; McNamer DK; Smith MJ; Burritt JB; Cutler JE
J Immunol; 1999 Jul; 163(2):826-33. PubMed ID: 10395676
[TBL] [Abstract][Full Text] [Related]
10. Rapid pathotyping of Newcastle disease virus using a single-chain Fv displayed on phage against the C-terminal end of the F2 polypeptide.
Li Y; Collins MS; Whitelam GC; Alexander DJ
Arch Virol; 2002 Oct; 147(10):2025-37. PubMed ID: 12376763
[TBL] [Abstract][Full Text] [Related]
11. A target-unrelated peptide in an M13 phage display library traced to an advantageous mutation in the gene II ribosome-binding site.
Brammer LA; Bolduc B; Kass JL; Felice KM; Noren CJ; Hall MF
Anal Biochem; 2008 Feb; 373(1):88-98. PubMed ID: 17976366
[TBL] [Abstract][Full Text] [Related]
12. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display.
Meyer SC; Gaj T; Ghosh I
Chem Biol Drug Des; 2006 Jul; 68(1):3-10. PubMed ID: 16923020
[TBL] [Abstract][Full Text] [Related]
13. Use of bacteriophage T7 displayed peptides for determination of monoclonal antibody specificity and biosensor analysis of the binding reaction.
Houshmand H; Fröman G; Magnusson G
Anal Biochem; 1999 Mar; 268(2):363-70. PubMed ID: 10075827
[TBL] [Abstract][Full Text] [Related]
14. Pathotyping of Newcastle disease virus with a filamentous bacteriophage.
Ramanujam P; Tan WS; Nathan S; Yusoff K
Biotechniques; 2004 Feb; 36(2):296-300, 302. PubMed ID: 14989094
[TBL] [Abstract][Full Text] [Related]
15. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
[TBL] [Abstract][Full Text] [Related]
16. Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry.
Xu Y; Ramsland PA; Davies JM; Scealy M; Nandakumar KS; Holmdahl R; Rowley MJ
Mol Immunol; 2004 Jun; 41(4):411-9. PubMed ID: 15163538
[TBL] [Abstract][Full Text] [Related]
17. A family of leukemia inhibitory factor-binding peptides that can act as antagonists when conjugated to poly(ethylene glycol).
Fairlie WD; Uboldi AD; Hemmings GJ; Smith BJ; Martin HM; Morgan PO; Baca M
Biochemistry; 2003 Nov; 42(45):13193-201. PubMed ID: 14609330
[TBL] [Abstract][Full Text] [Related]
18. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
[TBL] [Abstract][Full Text] [Related]
19. Effect of incubation temperature or maternal antibody on virus growth and mortality of embryonated chicken eggs inoculated with the B1 strain of lentogenic Newcastle disease virus.
Yachida S; Aoyama S; Takahashi N; Iritani Y; Katagiri K
Avian Dis; 1979; 23(4):983-8. PubMed ID: 546417
[TBL] [Abstract][Full Text] [Related]
20. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C
J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
